Biodyne바이오다인
314930 · KOSDAQ · ₩314930 · 바이오다인
₩5,890▲ ₩120 (2.08%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩7B | ₩5.3B | ₩4.1B | ₩12B | ₩3.8B |
| Cost of sales | ₩2.6B | ₩2.8B | ₩3.4B | ₩2.9B | ₩3.3B |
| Gross profit | ₩4.5B | ₩2.4B | ₩684M | ₩9.3B | ₩499M |
| Operating income | ₩652M | −₩1.7B | −₩2.1B | ₩6.7B | −₩2.3B |
| Net income | ₩852M | ₩11M | −₩992M | ₩5.6B | −₩11B |
| Net income to shareholders | ₩852M | ₩11M | −₩992M | ₩5.6B | −₩11B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩45B | ₩44B | ₩44B | ₩45B | ₩46B |
| Current assets | ₩19B | ₩22B | ₩21B | ₩23B | ₩28B |
| Cash and equivalents | ₩13B | ₩4.8B | ₩9.7B | ₩11B | ₩9.5B |
| Total liabilities | ₩871M | ₩1.1B | ₩604M | ₩1.3B | ₩7.3B |
| Current liabilities | ₩871M | ₩1.1B | ₩604M | ₩1.3B | ₩7.3B |
| Borrowings | — | ₩0 | ₩0 | ₩0 | ₩0 |
| Total equity | ₩44B | ₩43B | ₩43B | ₩44B | ₩38B |
| Shareholders' equity | ₩44B | ₩43B | ₩43B | ₩44B | ₩38B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩830M | ₩877M | ₩405M | ₩2.6B | −₩505M |
| Capital spending | ₩3.4B | ₩539M | ₩670M | ₩1.4B | ₩836M |
| Free cash flow | −₩2.6B | ₩338M | −₩265M | ₩1.2B | −₩1.3B |
Consolidated where available. Amounts in won.
Also known as: Biodyne / 바이오다인 / 314930 / KRX:314930
Source: KRX statistical information